DigestRedComo funciona
Red
/
Empresas
Od
No verificado

Odyssey Therapeutics, Inc.

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaMercado laboralSalud

10 Comunicados de prensa

Ver todos los comunicados de prensa
21/01/2026
Odyssey Therapeutics Appoints Jolie M. Siegel as Executive Vice President, General Counsel
Fuente
Odyssey Therapeutics, Inc.
Editor
Business Wire
1.00
0
11/11/2025
Odyssey Therapeutics Appoints Dennis Dean, Ph.D., as Executive Vice President, Head of Non-Clinical Development
Fuente
Odyssey Therapeutics, Inc.
Editor
Business Wire
1.00
0
09/10/2025
Odyssey Therapeutics Appoints Pharmaceutical Leader Nia Tatsis, Ph.D., to Its Board of Directors
Fuente
Odyssey Therapeutics, Inc.
Editor
Business Wire
1.00
0
10/09/2025
Biotecnología
Salud
Ciencia
Farmacéutica
Mercado laboral
Odyssey Therapeutics Announces Oversubscribed $213 Million Series D Financing to Advance Clinical Pipeline for Autoimmune Diseases
Fuente
Odyssey Therapeutics, Inc.
Editor
Business Wire
1.00
0
08/01/2025
Mercado laboral
Asociaciones/Profesionales
Salud
Finanzas
Farmacéutica
Biotecnología
Odyssey Therapeutics Appoints Jason Haas as Chief Financial Officer
Fuente
Odyssey Therapeutics, Inc.
Editor
Business Wire
1.00
0
28/10/2024
Mercado laboral
Técnica
Ciencia
Biotecnología
Salud
Farmacéutica
Tecnología de la información
Odyssey Therapeutics and Terray Therapeutics Enter Strategic Collaboration to Jointly Discover and Develop First-in-Class Transcription Factor Therapies
Fuente
Odyssey Therapeutics, Inc.
Editor
Business Wire
1.00
0
27/10/2024
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Odyssey Therapeutics to Present New Data on its Clinical-Stage RIPK2 Scaffolding Inhibitor, OD-07656, at the American College of Gastroenterology (ACG) Annual Scientific Meeting 2024
Fuente
Odyssey Therapeutics, Inc.
Editor
Business Wire
1.00
0
02/10/2024
Mercado laboral
Ciencia
VIH, SIDA y enfermedades autoinmunes
Biotecnología
Sanidad
Farmacéutica
Salud
Oncología
Odyssey Therapeutics Appoints Biopharma Veterans Timothy P. Walbert and Ian F. Smith to its Board of Directors
Fuente
Odyssey Therapeutics, Inc.
Editor
Business Wire
1.00
0
27/09/2024
Mercado laboral
Ciencia
Sanidad
Farmacéutica
Oncología
VIH, SIDA y enfermedades autoinmunes
Biotecnología
Medicina - Varios
Higiene alimentaria
Salud
Odyssey Therapeutics Announces Formation of Scientific Advisory Board
Fuente
Odyssey Therapeutics, Inc.
Editor
Business Wire
1.00
0
01/08/2024
Salud
Biotecnología
Ciencia
Farmacéutica
Mercado laboral
Odyssey Therapeutics Appoints Preeminent Chemist Dr. William Roush as Executive Vice President and Head of Small Molecule Research
Fuente
Odyssey Therapeutics, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0